PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30197637-5	2018	A combination of short chain fatty acids (SCFA) controlled the pathology in Abx treated mice, correlating to an increase in the frequency of Foxp3+, IL-17A+, and Foxp3+IL-17A+ double positive (Treg17) cells in tongue and oral draining lymph nodes.	Fatty Acids, Volatile	17-40	interleukin 17A	Mus musculus	149-155	
30197637-5	2018	A combination of short chain fatty acids (SCFA) controlled the pathology in Abx treated mice, correlating to an increase in the frequency of Foxp3+, IL-17A+, and Foxp3+IL-17A+ double positive (Treg17) cells in tongue and oral draining lymph nodes.	Fatty Acids, Volatile	17-40	interleukin 17A	Mus musculus	168-174	
34848335-8	2022	However, flow cytometry revealed that both the expression of CD4+Foxp3+ regulatory T cells and of IL-17-producing T cells were increased in the butyrate and SCFA mix groups.	Fatty Acids, Volatile	157-161	interleukin 17A	Mus musculus	98-103	
34848335-12	2022	SCFA supplementation did not result in a significant reduction in colon inflammation, but it promoted both regulatory T cell and IL-17-producing T cell expression, and increased both protective and aggressive gut microbiota.	Fatty Acids, Volatile	0-4	interleukin 17A	Mus musculus	129-134	
34233192-0	2021	Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal gammadelta T cells.	Fatty Acids, Volatile	23-46	interleukin 17A	Mus musculus	56-61